Polypharmacy and mortality association by chronic kidney disease status: The RE asons for G eographic A nd R acial D ifferences in S troke Study-Reference-Cited by-同舟云学术

Polypharmacy and mortality association by chronic kidney disease status: The RE asons for G eographic A nd R acial D ifferences in S troke Study

Published:2021-08 Issue:4 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Cashion Winn¹^ORCID,McClellan William¹,Judd Suzanne²,Goyal Abhinav¹,Kleinbaum David¹,Goodman Michael¹,Prince Valerie³,Muntner Paul⁴,Howard George²

Affiliation:

1. Department of Epidemiology Emory University Rollins School of Public Health Atlanta GA USA

2. Department of Biostatistics University of Alabama at Birmingham School of Public Health Birmingham AL USA

3. Department of Pharmacy Practice Samford University McWhorter School of Pharmacy Birmingham AL USA

4. Department of Epidemiology University of Alabama at Birmingham School of Public Health Birmingham AL USA

Funder

National Institute of Neurological Disorders and Stroke

National Institutes of Health

National Institute on Aging

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.823

Reference59 articles.

1. Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States

2. Geographic region and racial variations in polypharmacy in the United States

3. US FDA.Drug Applications for Over‐the‐Counter Drugs.2010.http://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/over‐the‐counterdrugs/default.htm. Accessed July 29 2012.

4. Benefits and Risks of Self Medication

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of polypharmacy with incidence of CKD: a retrospective cohort study: a letter to the Editor;Clinical and Experimental Nephrology;2023-12-19

2. Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference;Kidney International;2023-11

3. Polypharmacy, chronic kidney disease, and mortality among older adults: A prospective study of National Health and nutrition examination survey, 1999–2018;Frontiers in Public Health;2023-03-23

4. The Impact of Free Sugar on Human Health—A Narrative Review;Nutrients;2023-02-10

5. Polypharmacy in the Hospitalized Older Adult;Clinics in Geriatric Medicine;2022-11